Cardiovascular Safety of Rimegepant 75 mg in 3 Randomized Clinical Trials and Systematic Evaluations from In Vitro, Ex Vivo, and In Vivo Nonclinical Assays (2141)
Conway C, Croop R, Dubowchik G, Coric V, Lipton R. Cardiovascular Safety of Rimegepant 75 mg in 3 Randomized Clinical Trials and Systematic Evaluations from In Vitro, Ex Vivo, and In Vivo Nonclinical Assays (2141). Neurology 2020, 94 DOI: 10.1212/wnl.94.15_supplement.2141.Peer-Reviewed Original Research